Longitudinal Non-invasive Analysis of VOCAle Cord Function Based on Trans-laryngeal Ultrasound Acquisitions and Voice Recordings
VOCALISE
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
The main objective of VOCALISE study is to propose a new approach allowing a better characterization of postoperative dysphonia. This involves associating with dynamic translaryngeal ultrasound optimized acquisitions of the vibration of each vocal fold in phonation simultaneously with voice recordings. A software program to analyze the displacement of arytenoids, markers of substitution of the vocal cords, will be developed to finely quantify the mobility of laryngeal structures, by combining classical methods of motion analysis and deep learning methods. This approach will be evaluated to follow speech therapy rehabilitation in patients with post-operative dysphonia following recurrent nerve injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedFirst Posted
Study publicly available on registry
January 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
ExpectedJanuary 15, 2025
October 1, 2024
5 months
October 23, 2024
January 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the contribution of translaryngeal ultrasound combined with acoustic and perceptual measurements of voice and speech classically used in speech therapy for the rehabilitation of patients with dysphonia following surgery.
Correlation of each quantitative evaluation criterion proposed in ultrasound and voice and speech analysis with the classical voice quality criteria: the VHI (voice handicap index), the GRBASI scale (defined by 5 expert speech pathologists) and a set of acoustic measures of voice and speech.
6 months
Secondary Outcomes (3)
To visualise arytenoid motion in subjects with shadow artifact using the standard dTLUS approach, by optimising dTLUS acquisitions including curvilinear probe acquisitions, gel cushion acquisitions and lateral mode acquisitions.
6 months
To visualise arytenoid motion in subjects with shadow artifact using the standard dTLUS approach, by optimising dTLUS acquisitions including curvilinear probe acquisitions, gel cushion acquisitions and lateral mode acquisitions.
6 months
To visualise arytenoid motion in subjects with shadow artifact using the standard dTLUS approach, by optimising dTLUS acquisitions including curvilinear probe acquisitions, gel cushion acquisitions and lateral mode acquisitions.
6 months
Study Arms (1)
Patients diagnosed with dysphonia following cervical endocrine surgery
OTHERProspective single-center cohort study in patients diagnosed with dysphonia following cervical endocrine surgery
Interventions
"Dynamic translaryngeal Ultrasound Motion mode ultrasound of the laryngeal region during phonation Acoustic recordings VHI questionnaires "
Eligibility Criteria
You may qualify if:
- Patient over 18 years of age
- Obtaining patient's free and informed consent
- Patients with dysphonia following cervical surgery and referred for speech therapy
- Social security scheme membership (beneficiary or entitled), excluding MA
You may not qualify if:
- Known preoperative history of recurrent nerve paralysis (PR)
- History of laryngeal or vocal cord tumour
- Surgical complications preventing proper assessment of postoperative vocal cord mobility (tracheotomy, tracheal resection).
- Patients with a history of thyroid or parathyroid surgery or cervicotomy for another pathology
- Patient under guardianship or guardianship or deprived of liberty or under safeguard of justice
- Pregnant or nursing patient
- Patient does not read or has vision problems
- Cognitive and/or auditory impairment preventing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christophe TRESALLET, Pr, MD, PhD
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2024
First Posted
January 15, 2025
Study Start
January 1, 2025
Primary Completion
June 1, 2025
Study Completion (Estimated)
January 1, 2028
Last Updated
January 15, 2025
Record last verified: 2024-10